ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 115 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $78,430 | -14.9% | 23,695 | -15.9% | 0.02% | -19.0% |
Q1 2024 | $92,126 | -15.8% | 28,173 | -9.6% | 0.02% | -22.2% |
Q4 2023 | $109,417 | -52.1% | 31,173 | -8.8% | 0.03% | -55.0% |
Q3 2023 | $228,276 | -20.4% | 34,173 | 0.0% | 0.06% | -22.1% |
Q2 2023 | $286,711 | -15.5% | 34,173 | 0.0% | 0.08% | -23.0% |
Q1 2023 | $339,338 | +42.7% | 34,173 | 0.0% | 0.10% | +28.2% |
Q4 2022 | $237,844 | +30.7% | 34,173 | 0.0% | 0.08% | +21.9% |
Q3 2022 | $182,000 | +33.8% | 34,173 | 0.0% | 0.06% | +39.1% |
Q2 2022 | $136,000 | -10.5% | 34,173 | 0.0% | 0.05% | -11.5% |
Q1 2022 | $152,000 | -49.3% | 34,173 | 0.0% | 0.05% | -53.6% |
Q3 2021 | $300,000 | -22.5% | 34,173 | 0.0% | 0.11% | -26.8% |
Q2 2021 | $387,000 | -4.7% | 34,173 | 0.0% | 0.15% | -11.0% |
Q1 2021 | $406,000 | +73.5% | 34,173 | 0.0% | 0.17% | +60.7% |
Q4 2020 | $234,000 | -7.5% | 34,173 | 0.0% | 0.11% | -23.0% |
Q3 2020 | $253,000 | +76.9% | 34,173 | 0.0% | 0.14% | +65.5% |
Q2 2020 | $143,000 | +70.2% | 34,173 | 0.0% | 0.08% | +37.7% |
Q1 2020 | $84,000 | – | 34,173 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 1,877,305 | $10,025,000 | 5.86% |
Prosight Management, LP | 1,210,800 | $6,466,000 | 3.46% |
Perceptive Advisors | 11,350,085 | $60,609,000 | 1.76% |
JOHNSON & JOHNSON | 394,834 | $2,108,000 | 0.62% |
TANG CAPITAL MANAGEMENT LLC | 700,000 | $3,738,000 | 0.46% |
APOGEM CAPITAL LLC | 85,091 | $454,000 | 0.45% |
683 Capital Management, LLC | 700,000 | $3,738,000 | 0.29% |
EAM Investors, LLC | 233,638 | $1,248,000 | 0.27% |
Verition Fund Management LLC | 4,804,478 | $12,840,828 | 0.14% |
WOODSTOCK CORP | 129,179 | $690,000 | 0.10% |